Rote William E.insider trades
In SEC Form 4 filings, Rote William E. is listed as Chief Research Officer of Travere Therapeutics, Inc. (TVTX). In the last 90 days, Rote William E. sold $13.14M of Travere Therapeutics, Inc. (TVTX) on the open market and bought none. All 6 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Chief Research Officer | 16 | Sep 17 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M | 350 | $17.96 | $6,286 | 98,547 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M | 55,000 | $15.46 | $850,300 | 153,547 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M | 57,500 | $26.88 | $1,545,600 | 211,047 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | S | 65,104 | $63.12 | Sale −$4,109,397 | 145,943 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | S | 47,746 | $63.61 | Sale −$3,037,247 | 98,197 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M · derivative | 350 | $17.96 | $6,286 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M · derivative | 55,000 | $15.46 | $850,300 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M · derivative | 57,500 | $26.88 | $1,545,600 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 39,000 | $25.25 | $984,750 | 154,745 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 39,650 | $17.96 | $712,114 | 194,395 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 63,907 | $61.99 | Sale −$3,961,851 | 130,488 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 29,021 | $62.66 | Sale −$1,818,317 | 101,467 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 3,000 | $63.65 | Sale −$190,952 | 98,467 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 270 | $65.31 | Sale −$17,634 | 98,197 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 39,000 | $25.25 | $984,750 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 39,650 | $17.96 | $712,114 | 350 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.